Orchid Pharma Q3 FY25 Results
Orchid Pharma has released its financial results for the Q3 quarter of Financial Year 24-2025. Here's a comprehensive breakdown of the company's performance:
Revenue Analysis
- Current Quarter Revenue: Rs. 217.34 Cr
- Quarter-on-Quarter (QoQ) Change: -2.41% (Previous Quarter: Rs. 222.70 Cr )
- Year-on-Year (YoY) Change: -1.47% (Same Quarter Last Year: Rs. 220.59 Cr )
Profitability Metrics
- Net Profit: Rs. 20.78 Cr
- QoQ Profit Change: -23.72% (Previous Quarter: Rs. 27.24 Cr )
- YoY Profit Change: -29.41% (Same Quarter Last Year: Rs. 29.43 Cr )
Shareholder Returns
- Earnings Per Share (EPS): Rs. 4.10
- QoQ EPS Change: -23.65% (Previous Quarter: Rs. 5.37)
- YoY EPS Change: -33.66% (Same Quarter Last Year: Rs. 6.18)
Performance Summary
Challenging
Orchid Pharma faced some challenges with declining numbers. Management might need to address these issues.
This analysis provides a snapshot of Orchid Pharma's financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.
Disclaimer:
This information is for informational purposes only. Please reverify all details from official sources before making any financial decisions. The accuracy and completeness of this data cannot be guaranteed.